【24h】

Which patients should be tested for viruses on bronchoalveolar lavage fluid?

机译:哪些患者应该在支气管肺泡灌洗液中进行病毒检测?

获取原文
获取原文并翻译 | 示例
       

摘要

Bronchoalveolar lavage (BAL) is a major diagnostic tool in lung diseases, including viral respiratory infections. We aimed to better define the situations where viral tests should be performed on BAL fluid (BALF). We retrospectively studied all cases where viral tests [immunofluorescence, immunocytochemistry, viral culture, and/or polymerase chain reaction (PCR)] were performed on BALF during a period of 1 year (2008) in our institution. We compared the characteristics of patients with virus-positive versus virus-negative BALF. Of the 636 BALF samples sent to the microbiology laboratory, 232 underwent viral tests. Of these, 70 (30 %) were positive and identified 85 viruses: herpes simplex virus (HSV)-1 (n = 27), cytomegalovirus (CMV, n = 23), Epstein-Barr virus (EBV, n = 18), human herpesvirus (HHV)-6 (n = 12), respiratory syncytial virus (RSV, n = 3), rhinovirus (n = 1), and adenovirus (n = 1). The variables associated with positive viral tests on univariate analysis were immunosuppression [human immunodeficiency virus (HIV), corticosteroids >10 mg/day for ≥3 weeks, or other immunosuppressive therapy], ground-glass attenuations on computed tomography (CT) scanning, late-onset ventilator-associated pneumonia (VAP), and durations of (i) hospital stay, (ii) intensive care unit (ICU) stay, and (iii) mechanical ventilation before BAL (p < 0.01 for each comparison). On multivariate analysis, only immunosuppression [odds ratio (OR) 6.4, 95 % confidence interval (CI) [2.8-14.3], p < 0.0001] and ground-glass attenuations (OR 3.7, 95 % CI [1.8-7.7], p = 0.0004) remained associated with virus-positive BAL. None of the viral tests performed on BALF for the initial assessment of diffuse infiltrative lung disease (n = 15) was positive. PCR improved the diagnostic yield of viral tests on BALF by 50 %. Testing for viruses on BALF should be mostly restricted to immunocompromised patients with acute respiratory diseases and/or patients with unexplained ground-glass attenuations on CT scanning.
机译:支气管肺泡灌洗(BAL)是肺部疾病(包括病毒性呼吸道感染)的主要诊断工具。我们旨在更好地定义应对BAL液(BALF)进行病毒测试的情况。我们回顾性研究了在我们机构进行为期1年(2008年)的对BALF进行病毒检测[免疫荧光,免疫细胞化学,病毒培养和/或聚合酶链反应(PCR)]的所有病例。我们比较了病毒阳性BALF和病毒阴性BALF患者的特征。在送往微生物实验室的636份BALF样本中,有232份进行了病毒检测。其中70(30%)是阳性并鉴定出85种病毒:单纯疱疹病毒(HSV)-1(n = 27),巨细胞病毒(CMV,n = 23),爱泼斯坦-巴尔病毒(EBV,n = 18),人疱疹病毒(HHV)-6(n = 12),呼吸道合胞病毒(RSV,n = 3),鼻病毒(n = 1)和腺病毒(n = 1)。单因素分析中与阳性病毒检测有关的变量包括免疫抑制[人类免疫缺陷病毒(HIV),皮质类固醇> 10 mg / day≥3周或其他免疫抑制疗法],计算机断层扫描(CT)扫描的玻璃镜衰减,晚期呼吸机相关性肺炎(VAP),以及(i)住院时间,(ii)重症监护病房(ICU)住院时间和(iii)BAL前的机械通气时间(每次比较p <0.01)。在多变量分析中,只有免疫抑制[优势比(OR)6.4,95%置信区间(CI)[2.8-14.3],p <0.0001]和毛玻璃衰减(OR 3.7,95%CI [1.8-7.7],p = 0.0004)仍与病毒阳性BAL相关。在BALF上进行的用于弥漫性浸润性肺疾病的初步评估的病毒检测均无阳性(n = 15)。 PCR将BALF病毒检测的诊断率提高了50%。在BALF上进行病毒测试应主要限于免疫功能低下的急性呼吸道疾病患者和/或CT扫描中无法解释的毛玻璃衰减不明的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号